UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): October 27, 2004


                               INAMED CORPORATION

             (Exact name of registrant as specified in its charter)


         Delaware                       1-9741                    59-0920629
(State or other jurisdiction          (Commission               (IRS Employer
     of incorporation)                File Number)           Identification No.)


          5540 Ekwill Street                                   93111-2936
       Santa Barbara, California
(Address of principal executive offices)                       (Zip Code)

       Registrant's telephone number, including area code: (805) 683-6761


Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17
    CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
    CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
    Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
    Exchange Act (17 CFR 240.13e-4(c))




Item 2.02 Results of Operations and Financial Condition.

     On October 27, 2004, Inamed Corporation (the "Company") issued a press
release announcing its financial results for the third fiscal quarter ended
September 30, 2004. A copy of the press release is attached hereto as Exhibit
99.1.

     In accordance with General Instruction B.2 of Form 8-K, the information in
this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes
of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange
Act"), or otherwise subject to the liabilities of that section, nor shall it be
deemed incorporated by reference in any filing under the Securities Act of 1933,
as amended (the "Securities Act"), or the Exchange Act, except as expressly set
forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

     (c)  Exhibits.

          99.1  Press Release of Inamed Corporation, dated October 27, 2004.

                                       2



                                    SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                     INAMED CORPORATION

Date: October 27, 2004
                                                     By: /s/ Robert S. Vaters
                                                         -----------------------
                                                         Robert S. Vaters
                                                         Chief Financial Officer


                                       3